Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,195,000 | 16,056,000 | 11,188,000 | 21,355,000 | 7,246,000 |
| Depreciation Amortization | 4,681,000 | 5,755,000 | 6,150,000 | 6,269,000 | 5,757,000 |
| Income taxes - deferred | 2,288,000 | 561,000 | -2,204,000 | -2,410,000 | -700,000 |
| Accounts receivable | -1,275,000 | -1,124,000 | -458,000 | 259,000 | -134,000 |
| Other Working Capital | -307,000 | -3,902,000 | -334,000 | 1,334,000 | 98,000 |
| Other Operating Activity | -179,000 | -4,758,000 | 1,485,000 | -10,005,000 | 3,925,000 |
| Operating Cash Flow | $14,403,000 | $12,588,000 | $15,827,000 | $16,802,000 | $16,192,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,798,000 | 9,273,000 | 1,987,000 | -2,236,000 | 9,239,000 |
| PPE Investments | -2,226,000 | -2,046,000 | -1,984,000 | -1,956,000 | -1,823,000 |
| Net Acquisitions | N/A | -10,861,000 | N/A | -1,000,000 | -18,368,000 |
| Purchase Of Investment | -597,000 | -201,000 | -1,797,000 | -3,537,000 | -8,011,000 |
| Sale Of Investment | 723,000 | 232,000 | 6,244,000 | 3,579,000 | 11,268,000 |
| Purchase Sale Intangibles | N/A | N/A | -152,000 | -261,000 | -176,000 |
| Other Investing Activity | -373,000 | -342,000 | 75,000 | 410,000 | -96,000 |
| Investing Cash Flow | $-4,271,000 | $-3,945,000 | $4,525,000 | $-4,740,000 | $-7,791,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 8,223,000 | 19,006,000 | 2,094,000 | 9,886,000 | 4,412,000 |
| Debt Issued | 5,222,000 | 4,942,000 | 4,974,000 | 5,274,000 | 10,976,000 |
| Debt Repayment | -4,003,000 | -6,806,000 | -3,566,000 | -6,154,000 | -7,689,000 |
| Common Stock Issued | N/A | N/A | 1,259,000 | 862,000 | 1,019,000 |
| Common Stock Repurchased | 0 | -8,865,000 | -12,198,000 | -5,000,000 | -5,000,000 |
| Dividend Paid | -8,440,000 | -8,043,000 | -7,978,000 | -7,659,000 | -7,317,000 |
| Other Financing Activity | -10,651,000 | -8,719,000 | -5,026,000 | -10,559,000 | -5,629,000 |
| Financing Cash Flow | $-9,649,000 | $-8,485,000 | $-20,441,000 | $-13,350,000 | $-9,228,000 |
| Exchange Rate Effect | -8,000 | -32,000 | -116,000 | 53,000 | -215,000 |
| Beginning Cash Position | 1,350,000 | 1,225,000 | 1,431,000 | 2,666,000 | 3,707,000 |
| End Cash Position | 1,825,000 | 1,350,000 | 1,225,000 | 1,431,000 | 2,666,000 |
| Net Cash Flow | $475,000 | $125,000 | $-205,000 | $-1,235,000 | $-1,041,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,403,000 | 12,588,000 | 15,827,000 | 16,802,000 | 16,192,000 |
| Capital Expenditure | -2,226,000 | -2,046,000 | -1,984,000 | -1,956,000 | -1,823,000 |
| Free Cash Flow | 12,177,000 | 10,542,000 | 13,843,000 | 14,846,000 | 14,369,000 |